Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Jacqueline Trent"'
Autor:
Ramin Ramezani, Wenhao Zhang, Pamela Roberts, John Shen, David Elashoff, Zhuoer Xie, Annette Stanton, Michelle Eslami, Neil S Wenger, Jacqueline Trent, Antonia Petruse, Amelia Weldon, Andy Ascencio, Majid Sarrafzadeh, Arash Naeim
Publikováno v:
JMIR mHealth and uHealth, Vol 10, Iss 5, p e23887 (2022)
BackgroundOn-body wearable sensors have been used to predict adverse outcomes such as hospitalizations or fall, thereby enabling clinicians to develop better intervention guidelines and personalized models of care to prevent harmful outcomes. In our
Externí odkaz:
https://doaj.org/article/1f856ce2040f492eae99f585e4a38396
Autor:
Yvonne Y. Chen, Antoni Ribas, John M. Timmerman, Gary J. Schiller, Caspian Oliai, Patricia A. Young, Sven de Vos, Monica Mead, Karla Nawaly, Jonathan Said, Martin S. Allen-Auerbach, Melanie Ayala Ceja, Amr Almaktari, Stanley B. Gosliner, Beata Berent-Maoz, Thomas Schweppe, Mobina Khericha, Caitlin Harris, Mobina Roshandell, Jia Ming Chen, Jacqueline Trent, Jacob Naparstek, Sanaz N. Ghafouri, Brenda Ji, Christopher M. Walthers, Sarah M. Larson
CART19/20 cell product characteristics. (A) % CD4+ among total T cells and CAR-expressing T cells. (B) Comparison of T-cell subtype frequency among CD4+ vs. CD8+ T cells in cryopreserved CART19/20 cell products. Te/exh: effector/exhausted T cells, CD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e23adcca8d5d92e2da936e75c073574
https://doi.org/10.1158/2159-8290.22542543
https://doi.org/10.1158/2159-8290.22542543
Autor:
Yvonne Y. Chen, Antoni Ribas, John M. Timmerman, Gary J. Schiller, Caspian Oliai, Patricia A. Young, Sven de Vos, Monica Mead, Karla Nawaly, Jonathan Said, Martin S. Allen-Auerbach, Melanie Ayala Ceja, Amr Almaktari, Stanley B. Gosliner, Beata Berent-Maoz, Thomas Schweppe, Mobina Khericha, Caitlin Harris, Mobina Roshandell, Jia Ming Chen, Jacqueline Trent, Jacob Naparstek, Sanaz N. Ghafouri, Brenda Ji, Christopher M. Walthers, Sarah M. Larson
To address antigen escape and loss of T-cell functionality, we report a phase I clinical trial (NCT04007029) evaluating autologous naive and memory T (TN/MEM) cells engineered to express a bispecific anti-CD19/CD20 chimeric antigen receptor (CAR; CAR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::050a671732fa83e533f6d56dd43cca46
https://doi.org/10.1158/2159-8290.c.6549963
https://doi.org/10.1158/2159-8290.c.6549963
Autor:
Yvonne Y. Chen, Antoni Ribas, John M. Timmerman, Gary J. Schiller, Caspian Oliai, Patricia A. Young, Sven de Vos, Monica Mead, Karla Nawaly, Jonathan Said, Martin S. Allen-Auerbach, Melanie Ayala Ceja, Amr Almaktari, Stanley B. Gosliner, Beata Berent-Maoz, Thomas Schweppe, Mobina Khericha, Caitlin Harris, Mobina Roshandell, Jia Ming Chen, Jacqueline Trent, Jacob Naparstek, Sanaz N. Ghafouri, Brenda Ji, Christopher M. Walthers, Sarah M. Larson
Representativeness of study participants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e5e747491d7940bb0d582091c2fa708
https://doi.org/10.1158/2159-8290.22542522
https://doi.org/10.1158/2159-8290.22542522
Autor:
Sarah M. Larson, Christopher M. Walthers, Brenda Ji, Sanaz N. Ghafouri, Jacob Naparstek, Jacqueline Trent, Jia Ming Chen, Mobina Roshandell, Caitlin Harris, Mobina Khericha, Thomas Schweppe, Beata Berent-Maoz, Stanley B. Gosliner, Amr Almaktari, Melanie Ayala Ceja, Martin S. Allen-Auerbach, Jonathan Said, Karla Nawaly, Monica Mead, Sven de Vos, Patricia A. Young, Caspian Oliai, Gary J. Schiller, John M. Timmerman, Antoni Ribas, Yvonne Y. Chen
Publikováno v:
Cancer discovery.
To address antigen escape and loss of T-cell functionality, we report a phase I clinical trial (NCT04007029) evaluating autologous naive and memory T (TN/MEM) cells engineered to express a bispecific anti-CD19/CD20 chimeric antigen receptor (CAR; CAR
Autor:
Sanaz N Ghafouri, Christopher Walthers, Mobina Roshandell, Brenda Ji, Jacqueline Trent, Jia Ming Chen, Jacob Naparstek, Caitlin Harris, Karla Nawaly, Thomas Schweppe, Monica Mead, Sven de Vos, Patricia Young, Caspian Oliai, Gary J. Schiller, John M. Timmerman, Yvonne Y Chen, Sarah Larson
Publikováno v:
Transplantation and Cellular Therapy. 28:S53-S54
Autor:
Ramin Ramezani, Wenhao Zhang, Pamela Roberts, John Shen, David Elashoff, Zhuoer Xie, Annette Stanton, Michelle Eslami, Neil S Wenger, Jacqueline Trent, Antonia Petruse, Amelia Weldon, Andy Ascencio, Majid Sarrafzadeh, Arash Naeim
BACKGROUND On-body wearable sensors have been used to predict adverse outcomes such as hospitalizations or fall, thereby enabling clinicians to develop better intervention guidelines and personalized models of care to prevent harmful outcomes. In our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdb311a13f588364eca94ef7e750f1d7
https://doi.org/10.2196/preprints.23887
https://doi.org/10.2196/preprints.23887
Autor:
Ramin Ramezani, Wenhao Zhang, Pamela Roberts, John Shen, David Elashoff, Zhuoer Xie, Annette Stanton, Michelle Eslami, Neil S Wenger, Jacqueline Trent, Antonia Petruse, Amelia Weldon, Andy Ascencio, Majid Sarrafzadeh, Arash Naeim
Publikováno v:
JMIR mHealth and uHealth. 10(5)
Background On-body wearable sensors have been used to predict adverse outcomes such as hospitalizations or fall, thereby enabling clinicians to develop better intervention guidelines and personalized models of care to prevent harmful outcomes. In our
Autor:
Karla K. Nawaly, Patricia A. Young, John M. Timmerman, Brenda Y. Ji, Gary J. Schiller, Monica Mead, Caitlin Harris, Christopher Walthers, Jia Ming Chen, Sanaz Ghafouri, Sven de Vos, Thomas Schweppe, Jacob Naparstek, Mobina Roshandell, Yvonne Y. Chen, Sarah Larson, Jacqueline Trent, Caspian Oliai
Publikováno v:
Cancer Research. 81:CT007-CT007
50% of patients with relapsed/refractory (R/R) B-cell lymphomas (BCL) who initially respond to CD19 CAR T therapy will relapse either due to poor CAR-T persistence or CD19 antigen escape. Preclinical data demonstrate that engineering of bispecific an
Autor:
Brenda Y. Ji, John M. Timmerman, Monica Mead, Jia Ming Chen, Sanaz Ghafouri, Jacqueline Trent, Christopher M. Walthers, Jacob Naparstek, Mobina Roshandell, Yvonne Y. Chen, Sarah Larson
Publikováno v:
Blood. 136:19-20
Background: Single-input anti-CD19 CAR T-cells have demonstrated clinical efficacy for relapsed or refractory (R/R) non-Hodgkin B-cell lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Despite excellent response rates, over 50% of CD19 CAR T-cel